Meta introduces camera-free AI glasses
Meta says the camera-free glasses will be lighter and have up to 12 hours battery life.
Redefining enterprise intelligence with autonomous AI
Enterprise AI is no longer a future ambition. It is in full operational flight. Model capabilities are advancing faster than most organizations can absorb, while the cost of performance continues to fall. Globally, AI investment is set to reach $2.5 trillion in 2026, up 44% from the previous year. For many enterprises, this investment has…
Vogue sent robots down the runway at Vogue World, and people were not impressed
Nothing says Italian craftsmanship like a Chinese robot doing a lasso to “L’Amour Toujours.”
The Difference Between Founders Who Last and Those Who Burn Out
The founders still standing in year 10 all learned the same skill: knowing when to stop.
Nvidia’s Open Weight Letter Is More About AI Sovereignty Than Anything
Businesses gain greater control over model stability, data, infrastructure, costs, security and the knowledge they build with open weights.
Anthropic says its biology lab has already found something big
But maybe the biggest reveal is that Anthropic has not let Claude run lose in its biology lab. Humans are still, so far, in the loop.
If Amazon doesn’t know how to eliminate carbon emissions, then who does?
Amazon is one of the largest companies in the world. How much responsibility does it have to meet its net zero pledge?
VC firm Bessemer now has another $5.75B to invest in (what else?) AI
The VC firm says that AI-native companies are growing faster than any technology, ever.
The Difference Between Founders Who Last and Those Who Burn Out
The founders still standing in year 10 all learned the same skill: knowing when to stop.
The Concept of Bringing Iced Coffee to a Job Interview Is Dividing Generations. A Career Expert Reveals an Even More ‘Awkward’ Mistake.
Some younger job candidates are pushing back against traditional interview etiquette.
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.